secwatch.observer — SEC 8-K summary
======================================

Issuer:     Mirum Pharmaceuticals, Inc. (MIRM)
CIK:        0001759425
Form:       8-K
Filed at:   2022-12-19T23:59:59+00:00
Accession:  0001193125-22-307926
Event type: leadership
Sentiment:  neutral
Materiality: 0.35
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Mirum Pharmaceuticals director Carol Brosgart resigns, becomes senior advisor; Lon Cardon appointed to board
--------------------------------------------------------------------------------

- Carol L. Brosgart resigned as director and Nominating Committee member effective Dec 19, 2022; no dispute; becomes senior advisor in science and policy.
- Lon Cardon, Ph.D., appointed to board as Class I director, term expiring at 2023 annual meeting, and to Nominating and Corporate Governance Committee.
- Cardon receives option for 34,000 shares vesting in 3 equal annual installments, plus annual cash retainer of $40,000 ($4,000 for committee service) prorated for 2022.
- Cardon eligible for annual option grant of 17,000 shares starting at 2023 annual meeting, prorated per policy.
- Standard indemnification agreement entered; no arrangements with other persons for selection.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1759425/000119312522307926/0001193125-22-307926-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1759425/000119312522307926/d436545d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-307926

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer